Selective Antagonism at Dopamine D3 Receptors as a Target for Drug Addiction Pharmacotherapy: A Review of Preclinical Evidence

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|7|5|410-421

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.7, Iss.5, 2008-11, pp. : 410-421

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of 5-HT3 Receptors in Drug Abuse and as a Target for Pharmacotherapy

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 5, 2008-11 ,pp. : 454-467

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of selective activation of dopamine D 2 and D 3 receptors on prolactin secretion and the activity of tuberoinfundibular dopamine neurons

By Durham R.A.   Eaton M.J.   Moore K.E.   Lookingland K.J.  

European Journal of Pharmacology, Vol. 335, Iss. 1, 1997-09 ,pp. : 37-42

Elsevier

Access to resources Recommend Favorite

Evidence that dopamine D 3 receptors participate in clozapine-induced hypothermia

By Millan M.J.   Audinot V.   Melon C.   Newman-Tancredi A.  

European Journal of Pharmacology, Vol. 280, Iss. 2, 1995-07 ,pp. : 225-229

Elsevier

Access to resources Recommend Favorite

Muscarinic receptors: a novel therapeutic target for drug addiction

By Yang G.  

Trends in Pharmacological Sciences, Vol. 23, Iss. 12, 2002-12 ,pp. : 551-551

Elsevier

Access to resources Recommend Favorite

Neuronal Nicotinic Receptors as Brain Targets for Pharmacotherapy of Drug Addiction

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 5, 2008-11 ,pp. : 422-441

Bentham Science Publishers

Access to resources Recommend Favorite